These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa. Chowdhury TG; Chen YW; Aoki C J Vis Exp; 2015 Oct; (105):e52927. PubMed ID: 26555618 [TBL] [Abstract][Full Text] [Related]
4. Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice. Klenotich SJ; Seiglie MP; McMurray MS; Roitman JD; Le Grange D; Dugad P; Dulawa SC Neuropsychopharmacology; 2012 Jun; 37(7):1620-31. PubMed ID: 22395732 [TBL] [Abstract][Full Text] [Related]
5. Timing matters: The contribution of running during different periods of the light/dark cycle to susceptibility to activity-based anorexia in rats. Aston SA; Caffo BS; Bhasin H; Moran TH; Tamashiro KL Physiol Behav; 2023 Nov; 271():114349. PubMed ID: 37709000 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in response to activity-based anorexia model in C57Bl/6 mice. Achamrah N; Nobis S; Goichon A; Breton J; Legrand R; do Rego JL; do Rego JC; Déchelotte P; Fetissov SO; Belmonte L; Coëffier M Physiol Behav; 2017 Mar; 170():1-5. PubMed ID: 27979627 [TBL] [Abstract][Full Text] [Related]
7. Three daily intraperitoneal injections of sub-anesthetic ketamine ameliorate activity-based anorexia vulnerability of adult female mice. Goodwin-Groen S; Dong Y; Aoki C Int J Eat Disord; 2023 Aug; ():. PubMed ID: 37530601 [TBL] [Abstract][Full Text] [Related]
8. The effect of pre-exposure and recovery type on activity-based anorexia in rats. Ratnovsky Y; Neuman P Appetite; 2011 Jun; 56(3):567-76. PubMed ID: 21281687 [TBL] [Abstract][Full Text] [Related]
9. Activity-Based Anorexia Reduces Body Weight without Inducing a Separate Food Intake Microstructure or Activity Phenotype in Female Rats-Mediation via an Activation of Distinct Brain Nuclei. Scharner S; Prinz P; Goebel-Stengel M; Kobelt P; Hofmann T; Rose M; Stengel A Front Neurosci; 2016; 10():475. PubMed ID: 27826222 [TBL] [Abstract][Full Text] [Related]
10. Role of spontaneous physical activity in prediction of susceptibility to activity based anorexia in male and female rats. Perez-Leighton CE; Grace M; Billington CJ; Kotz CM Physiol Behav; 2014 Aug; 135():104-11. PubMed ID: 24912135 [TBL] [Abstract][Full Text] [Related]
11. Development of, and recovery from, activity-based anorexia in female rats. Dixon DP; Ackert AM; Eckel LA Physiol Behav; 2003 Nov; 80(2-3):273-9. PubMed ID: 14637226 [TBL] [Abstract][Full Text] [Related]
12. Evaluating anhedonia in the activity-based anorexia (ABA) rat model. Milton LK; Oldfield BJ; Foldi CJ Physiol Behav; 2018 Oct; 194():324-332. PubMed ID: 29913226 [TBL] [Abstract][Full Text] [Related]
13. Alteration of intestinal barrier function during activity-based anorexia in mice. Jésus P; Ouelaa W; François M; Riachy L; Guérin C; Aziz M; Do Rego JC; Déchelotte P; Fetissov SO; Coëffier M Clin Nutr; 2014 Dec; 33(6):1046-53. PubMed ID: 24290874 [TBL] [Abstract][Full Text] [Related]
14. Exercise, diet, and the reinforcing value of food in an animal model of anorexia nervosa. de Paz A; Vidal P; Pellón R Q J Exp Psychol (Hove); 2019 Jul; 72(7):1692-1703. PubMed ID: 30282528 [TBL] [Abstract][Full Text] [Related]
15. Activity-based anorexia animal model: a review of the main neurobiological findings. Spadini S; Ferro M; Lamanna J; Malgaroli A J Eat Disord; 2021 Oct; 9(1):123. PubMed ID: 34600568 [TBL] [Abstract][Full Text] [Related]
16. Ghrelin treatment prevents development of activity based anorexia in mice. Legrand R; Lucas N; Breton J; Azhar S; do Rego JC; Déchelotte P; Coëffier M; Fetissov SO Eur Neuropsychopharmacol; 2016 Jun; 26(6):948-58. PubMed ID: 27052473 [TBL] [Abstract][Full Text] [Related]
17. Leptin treatment in activity-based anorexia. Hillebrand JJ; Koeners MP; de Rijke CE; Kas MJ; Adan RA Biol Psychiatry; 2005 Jul; 58(2):165-71. PubMed ID: 16038687 [TBL] [Abstract][Full Text] [Related]
18. Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2. Lewis DY; Brett RR Eur Neuropsychopharmacol; 2010 Sep; 20(9):622-31. PubMed ID: 20471226 [TBL] [Abstract][Full Text] [Related]